Compound ID | 2266
Class: Membrane-active agent
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Membrane-active agent. Interacts with and disrupts a bacterial mimetic lipid bilayer but not mammalian membranes |
| Target Pathogen: | Active against Staphylococcus aureus including persister cells |
| Description: | Synthetic compound (retinoid); a repurposed FDA-approved anthelminthic drug; >64 ug/ml haemolytic activity and membrane permeabilization against human erythrocytes and HKC-8 human renal proximal cells respectively (MIC at 0.5-2 ug/ml; shows efficacy in mouse MRSA infection model when in combination with gentamicin |
| Year first mentioned: | 2019 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/2406#section=Structures |
| Citations: |
|